Mark Schoenberg
CIK 1763581 · Chief Medical Officer · last filed 2026-07-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.22M
Companies
1
Total Filings
64
Lifetime Open-Market Net
-$2.48M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| URGN | Chief Medical Officer | 127,730 | $40.88 | $5.22M | -$2.48M | 51 | 2026-07-10 |
Recent Filings · Page 4 of 7
64 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-09-08 | URGN | Grant (A) | — | $0 | EDGAR |
| 2023-06-09 | URGN | Grant (A) | — | $0 | EDGAR |
| 2023-02-02 | URGN | Mixed | +1,933 | -$19.2K | EDGAR |
| 2023-01-23 | URGN | Exer (M) | +122,677 | $613.4K | EDGAR |
| 2022-11-02 | URGN | Mixed | +242 | -$3.1K | EDGAR |
| 2022-08-25 | URGN | Mixed | +241 | -$2.0K | EDGAR |
| 2022-05-03 | URGN | Mixed | +246 | -$1.7K | EDGAR |
| 2022-02-02 | URGN | Mixed | +1,126 | -$10.4K | EDGAR |
| 2022-01-28 | URGN | Mixed | +98 | -$898 | EDGAR |
| 2021-11-19 | URGN | Buy (P) | +160 | $2.1K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.